Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction 
 
Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare contract research organization helps in improvement of people by offering professional and high quality service solutions. The report provides analysis of global healthcare contract research organization (CRO) market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global healthcare contract research organization (CRO) market is anticipated to grow at considerable CAGR above 6.5% over the forecast period and reach US$ 54.82 Bn by 2026. 
 
Market Dynamics
 
With expanding number of organizations to recognize biologics and new mixes, and growing R&D costs, medicate creators and support organizations are feeling the squeeze to supplant income misfortune explicitly because of generics. This has further made drug development more complex expensive and hence augmenting the market growth. In various countries due to complex regulatory framework for drug discovery and development, the need for expertise for drug development is increasing, thereby boosting the demand for outsourcing services. With growing privatization of clinical trials, the outsourcing of manufacturing processes is increasing in developing countries. 
 
Moreover, increasing pressure on industry players to follow rigorous regulations as well as timelines is supplementing the demand for outsourcing of research activities. Government organizations are also outsourcing their clinical trials to various contract research organizations for required infrastructure and expertise. Healthcare CROs’ are enhancing their portfolio by integrating services with advanced technology in order to deliver desired and efficient results to clients. However, lack of skilled research professionals may hinder the growth of the overall market.
 
Market Segmentation

Market by Product

  • Drug Discovery
    • Target validation
    • Lead identification
    • Lead optimization
  • Pre-Clinical
  • Clinical
  • Phase I Trial Services
  • Phase II Trial Services
  • Phase III Trial Services
  • Phase IV Trial Services

Market by Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and site Recruitment
  • Technology
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA
The market research study on “Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global healthcare contract research organization (CRO)market entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global healthcare contract research organization (CRO)market by type, service and major geographic regions. The report also covers basic healthcare development policies. Secondly, the report covers global healthcare contract research organization (CRO) market size and segment markets by type, service and geography along with the information on companies operating in the market. 

Report Coverage

Market

Healthcare Contract Research Organization (CRO) Market

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Intervention, Distribution method and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 
Market Participants
 
The company profiling of key players in the global healthcare contract research organization (CRO) market includes company overview, major business strategies and revenues. The key players of the market are Laboratory Corporation of America Holdings, PRA Health Sciences, Charles River Laboratories, Inc., Pharmaceutical Product Development, LLC, Quintiles IMS Holdings, Inc., PAREXEL International Corporation, inVentiv Health, Inc. and ICON plc.


Related Reports

Minimally Invasive Surgical Instruments Market (By Device: Handheld Instruments, -Inflation Devices, Cutter Instruments, Guiding Devices, Electrosurgical Devices, Auxiliary Devices, Monitoring & Visualization Devices; By Application: Cardiac, Gastrointestinal, Orthopedic, Vascular, Gynecological, Urological, Thoracic, Cosmetic, Dental, Others; By End-user: Hospitals & Clinics, Ambulatory Surgical Centers) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global minimally invasive surgical instruments is market size is anticipated to around USD 39.0 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The inclination for Minimally Invasive Surgical (MIS) techniques is increasing as they are less traumatic and they encourage quicker recoup process than

NET Treatment Market (By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Others; By Site: Lungs, Pancreas, Colon, Small Intestine, Others; By End-user: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global NET treatment is market size is anticipated to around USD 4.2 billion by 2026, this market is anticipated to grow with 10.1% CAGR during the forecast time period. The market is driven by growing occurrence of cancer among patients is expected to drive NET treatment market growth across the global.

Embolic Protection Devices Market (By Product: Distal Occlusion Filters, Proximal Occlusion Filters, Distal Filters; By Application: Neurovascular Diseases, Cardiovascular Diseases, Peripheral Vascular Diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global embolic protection devices market size is anticipated to reach USD 2.0 billion by 2026, registering at a CAGR growth of 9.2% over the forecast period. Increasing cases of cardiovascular, neurovascular surgeries and also surge in huge investments in R&D of embolic devices are the main features driving the market development.

Cart Summary